Active Ingredient History
Fenofibrate, is an oral medication of the fibrate class used to treat abnormal blood lipid levels. It is less commonly used compared than statins because it treats a different type of cholesterol abnormality to statins. While statins have strong evidence for reducing heart disease and death, there is evidence to suggest that fenofibrate also reduces the risk of heart disease and death. However, this seems only to apply to specific populations of people with elevated triglyceride levels and reduced high-density lipoprotein (HDL) cholesterol. Its use is recommended together with dietary changes. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Coronary Syndrome (Phase 4)
Albuminuria (Phase 4)
Alcoholism (Phase 2)
Atherosclerosis (Phase 4)
Burns (Phase 4)
Cholangitis, Sclerosing (Phase 1/Phase 2)
Cholestasis (Phase 2)
Cholesterol, HDL (Phase 4)
Chylomicrons (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 4)
COVID-19 (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 4)
Diabetic Retinopathy (Phase 4)
Drugs, Investigational (Phase 4)
Dyslipidemias (Phase 4)
Ependymoma (Phase 2)
Fenofibrate (Phase 1)
Genetic Diseases, Inborn (Phase 4)
Glucose Metabolism Disorders (Phase 3)
Glucuronosyltransferase (Phase 1)
Healthy Volunteers (Phase 2)
HIV (Phase 4)
HIV Infections (Phase 4)
Huntington Disease (Phase 2)
Hyperlipidemia, Familial Combined (Phase 4)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 3)
Hyperlipoproteinemia Type III (Phase 3)
Hypertension (Phase 4)
Hypertriglyceridemia (Phase 4)
Inflammatory Bowel Diseases (Phase 2/Phase 3)
Insulin Resistance (Phase 4)
Kidney Diseases (Phase 3)
Klinefelter Syndrome (Phase 4)
Leukemia (Phase 2)
Lipodystrophy (Phase 3)
Liver Cirrhosis, Biliary (Phase 3)
Liver Transplantation (Phase 2)
Lymphoma (Phase 2)
Macula Lutea (Phase 2)
Macular Edema (Phase 2)
Medulloblastoma (Phase 2)
Metabolic Syndrome (Phase 4)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 4)
Overweight (Phase 2)
Pharmacokinetics (Phase 1)
Protease Inhibitors (Phase 1)
Respiratory Distress Syndrome (Phase 3)
Rhabdoid Tumor (Phase 2)
Sarcoma (Phase 2)
Sexual Dysfunction, Physiological (Phase 4)
Sleep Apnea Syndromes (Phase 2)
Spinal Cord Injuries (Phase 2/Phase 3)
Vascular Diseases (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue